Rakuten Securities’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Rakuten Securities’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35K	Sell	40 -50	-56%	-$1.67K	﹤0.01%	696
2026 Q1	$2.71K	Sell	90 -1,143	-93%	-$36.8K	﹤0.01%	579
2025 Q4	$38.5K	Sell	1,233 -46	-4%	-$1.13K	0.01%	263
2025 Q3	$25.8K	Sell	1,279 -70	-5%	-$1.23K	0.01%	295
2025 Q2	$22.6K	Sell	1,349 -113	-8%	-$1.82K	0.01%	308
2025 Q1	$22.5K	Buy	1,462 +1,160	+384%	+$20.7K	0.01%	297
2024 Q4	$6.66K	Sell	302 -730	-71%	-$13.3K	﹤0.01%	438
2024 Q3	$18.6K	Buy	1,032 +7	+0.7%	+$123	0.01%	274
2024 Q2	$16.7K	Buy	1,025 +3	+0.3%	+$46	0.01%	276
2024 Q1	$14.4K	Buy	+1,022	New	+$12.9K	0.01%	287

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Rakuten Securities's TEVA Position: Q2 2026 in Review

Rakuten Securities reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 56% in Q2 2026, selling an estimated $1.67K and leaving 40 shares worth $1.35K. The position accounts for ﹤0.01% of the portfolio, ranked #696.

Rakuten Securities first reported a position in TEVA in Q1 2024 and has held it in 10 quarters since. The position peaked at $38.5K in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Rakuten Securities held 40 shares of Teva Pharmaceutical Industries Limited worth $1.35K as of Q2 2026.
Rakuten Securities sold 50 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $1.67K.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #696 holding.
Rakuten Securities first reported a position in Teva Pharmaceutical Industries Limited in Q1 2024 and has held it in 10 quarters since.
Rakuten Securities's Teva Pharmaceutical Industries Limited position peaked at $38.5K in Q4 2025.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.